Evidence map›Paper›PMID 27808415›Full record

Trial reportThe Laryngoscope2017

An open-label study of sodium oxybate in Spasmodic dysphonia.

Anna F Rumbach, Andrew Blitzer, Steven J Frucht, Kristina Simonyan

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Laryngoscope, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01961297 phase2completednot on this map

Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response

TypeinterventionalSponsorKristina SimonyanRan2012 to 2017Enrolled53ConditionsSpasmodic Dysphonia, Voice TremorArmsSodium oxybate
NCT03292458 phase2 / phase3completednot on this mapstarted 2018, after this paper: background citation

Central Mechanisms and Treatment Response of Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor

TypeinterventionalSponsorKristina SimonyanRan2018 to 2024Enrolled117ConditionsSpasmodic Dysphonia, Voice TremorArmsSodium Oxybate
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Sodium Oxybate in Alcohol-Responsive Essential Tremor of Voice: An Open-Label Phase II Study.Movement disorders : official journal of the Movement Disorder Society · 2023
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Laryngeal dystonia: a comprehensive review of aetiology, clinical presentation, diagnosis, and treatment approaches.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Spasmodic Dysphonia.World journal of otorhinolaryngology - head and neck surgery · 2025
    Review
  11. Treatment of Neurogenic Voice Disorders.World journal of otorhinolaryngology - head and neck surgery · 2025
    Review
  12. Article
  13. Temporal Signature of Task-Specificity in Isolated Focal Laryngeal Dystonia.Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Anna F RumbachSchool of Health and Rehabilitation Sciences, Speech Pathology, University of Queensland, Brisbane, Queensland, Australia.
Andrew BlitzerDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, U.S.A.
Steven J FruchtDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, U.S.A.
Kristina SimonyanDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, U.S.A.
Icahn School of Medicine at Mount Sinai · USQueensland Health · AU

Funding

Voice tremor in spasmodic dysphonia: central mechanisms and treatment responseR01DC012545 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI SIMONYAN, KRISTINA · 2012 to 2021
$5.2M
NIDCD NIH HHS R01 DC012545
6 · The paper itself

Abstract

objectives/hypothesisSpasmodic dysphonia (SD) is a task-specific laryngeal dystonia that affects speech production. Co-occurring voice tremor (VT) often complicates the diagnosis and clinical management of SD. Treatment of SD and VT is largely limited to botulinum toxin injections into laryngeal musculature; other pharmacological options are not sufficiently developed. STUDY

designOpen-label study.

methodsWe conducted an open-label study in 23 SD and 22 SD/VT patients to examine the effects of sodium oxybate (Xyrem), an oral agent with therapeutic effects similar to those of alcohol in these patients. Blinded randomized analysis of voice and speech samples assessed symptom improvement before and after drug administration.

resultsSodium oxybate significantly improved voice symptoms (P = .001) primarily by reducing the number of SD-characteristic voice breaks and severity of VT. Sodium oxybate further showed a trend for improving VT symptoms (P = .03) in a subset of patients who received successful botulinum toxin injections for the management of their SD symptoms. The drug's effects were observed approximately 30 to 40 minutes after its intake and lasted about 3.5 to 4 hours.

conclusionsOur study demonstrated that sodium oxybate reduced voice symptoms in 82.2% of alcohol-responsive SD patients both with and without co-occurring VT. Our findings suggest that the therapeutic mechanism of sodium oxybate in SD and SD/VT may be linked to that of alcohol, and as such, sodium oxybate might be beneficial for alcohol-responsive SD and SD/VT patients. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:1402-1407, 2017.

Indexed as

AdultAgedDysphoniaEthanolFemaleHumansMaleMiddle AgedNeurotransmitter AgentsSingle-Blind MethodSodium OxybateSpeechTreatment OutcomeVoiceVoice DisordersEthanolNeurotransmitter AgentsSodium OxybatealcoholLaryngeal dystoniaXyrem

Identifiers

PMID27808415
PMCPMC5415435
OpenAlexW2548237762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.